0001054274-14-000002.txt : 20140515 0001054274-14-000002.hdr.sgml : 20140515 20140514175351 ACCESSION NUMBER: 0001054274-14-000002 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20140515 DATE AS OF CHANGE: 20140514 EFFECTIVENESS DATE: 20140515 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Alliqua, Inc. CENTRAL INDEX KEY: 0001054274 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] IRS NUMBER: 582349413 STATE OF INCORPORATION: FL FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-217404 FILM NUMBER: 14842882 BUSINESS ADDRESS: STREET 1: 2150 CABOT BOULEVARD WEST CITY: LANGHORNE STATE: PA ZIP: 19047 BUSINESS PHONE: 215-702-8550 MAIL ADDRESS: STREET 1: 2150 CABOT BOULEVARD WEST CITY: LANGHORNE STATE: PA ZIP: 19047 FORMER COMPANY: FORMER CONFORMED NAME: HEPALIFE TECHNOLOGIES INC DATE OF NAME CHANGE: 20030529 FORMER COMPANY: FORMER CONFORMED NAME: ZETA CORP DATE OF NAME CHANGE: 20030219 FORMER COMPANY: FORMER CONFORMED NAME: ZETA CORP /CA DATE OF NAME CHANGE: 20000303 D 1 primary_doc.xml X0707 D LIVE 0001054274 Alliqua, Inc. 2150 CABOT BOULEVARD WEST LANGHORNE PA PENNSYLVANIA 19047 215-702-8550 FLORIDA HEPALIFE TECHNOLOGIES INC ZETA CORP ZETA CORP /CA Corporation true David Stefansky 2150 CABOT BOULEVARD WEST LANGHORNE PA PENNSYLVANIA 19047 Director Jerome Zeldis 2150 CABOT BOULEVARD WEST LANGHORNE PA PENNSYLVANIA 19047 Director Joseph Leone 2150 CABOT BOULEVARD WEST LANGHORNE PA PENNSYLVANIA 19047 Director Kenneth Pearsen 2150 CABOT BOULEVARD WEST LANGHORNE PA PENNSYLVANIA 19047 Director Jeffrey Sklar 2150 CABOT BOULEVARD WEST LANGHORNE PA PENNSYLVANIA 19047 Director Brian Posner 2150 CABOT BOULEVARD WEST LANGHORNE PA PENNSYLVANIA 19047 Executive Officer Chief Financial Officer, Treasurer and Secretary of the Issuer David Johnson 2150 CABOT BOULEVARD WEST LANGHORNE PA PENNSYLVANIA 19047 Executive Officer Director President, Chief Executive Officer and Director of the Issuer Perry Karsen 2150 CABOT BOULEVARD WEST LANGHORNE PA PENNSYLVANIA 19047 Director Biotechnology Decline to Disclose 06b false 2014-05-05 true true true 0 7003080 2003080 5000000 The former stockholders of Choice Therapeutics, Inc. may receive in aggregate up to an additional $5 million in shares of the Common Stock of Alliqua, Inc., in an earnout payment 37 months following the closing. true 0 43 0 0 0 false Alliqua, Inc. /s/ Brian Posner Brian Posner Chief Financial Officer 2014-05-14